Impact of Lithium Treatment on FGF-23 Serum Concentrations in Depressive Patients

被引：0
|
作者：
Fakhri, Hajar [1 ]
Ricken, Roland [2 ]
Adli, Mazda [2 ]
Fajol, Abul [1 ]
Walter, Marc [3 ]
Foeller, Michael [1 ]
Lang, Florian [1 ]
Lang, Undine E. [3 ]
Lange, Claudia [3 ]
机构：
[1] Univ Tubingen, Dept Physiol, Tubingen, Germany
[2] Charite, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany
[3] Univ Basel, Univ Psychiat Clin, Basel, Switzerland
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2014年 / 34卷 / 06期
关键词：
FIBROBLAST-GROWTH-FACTOR; VITAMIN-D; PHOSPHATE; FGF23; INCREASE; D-3;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：745 / 747
页数：4
相关论文
共 50 条
  • [41] Tenapanor Controls Serum Phosphorus and Reduces PTH and FGF-23 in Patients on Dialysis with Severe Secondary Hyperparathyroidism
    Weiner, Daniel E.
    Spiegel, David M.
    Yang, Yang
    Rosenbaum, David P.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 6 - 6
  • [42] Serum human FGF-23 level in X-linked hypophosphatemic rickets
    Takaiwa, M
    Ueda, K
    Shimizu, J
    Namba, N
    Yamanaka, Y
    Inoue, M
    Tanaka, H
    Seino, Y
    BONE, 2003, 32 (05) : S118 - S118
  • [43] PAMIDRONATE TREATMENT IN A PATIENT WITH FIBROUS DYSPLASIA OF THE JAW AND FGF-23 MUTATION
    Marcucci, G.
    Gozzini, A.
    Leoncini, G.
    Franceschelli, F.
    Barbaro, V.
    Rossi, M.
    Forti, G.
    Emmi, L.
    Brandi, M. L.
    De Feo, M. L.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 328 - 329
  • [44] Circulating FGF-23 concentrations in oncogenic hypophosphatemic osteomalacia (OHO) patients pre- and post-surgery
    White, KE
    Evans, WE
    Shulman, DI
    Colussi, G
    Moe, SM
    Peacock, M
    Econs, MJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S211 - S211
  • [45] Alteration in serum concentrations of FGF19, FGF21, and FGF23 in patients with urothelial carcinoma
    Li, Jian-Ri
    Chiu, Kun-Yuan
    Ou, Yen-Chuan
    Wang, Shian-Shiang
    Chen, Chuan-Su
    Yang, Cheng-Kuang
    Ho, Hao-Chung
    Cheng, Chen-Li
    Yang, Chi-Rei
    Chen, Cheng-Che
    Wang, Shu-Chi
    Lin, Chia-Yen
    Hung, Sheng-Chun
    Hsu, Chiann-Yi
    Chen, Chun-Jung
    BIOFACTORS, 2019, 45 (01) : 62 - 68
  • [46] FGF-23 and the Progression of Coronary Arterial Calcification in Patients New to Dialysis
    Khan, Abigail May
    Chirinos, Julio A.
    Litt, Harold
    Yang, Wei
    Rosas, Sylvia E.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (12): : 2017 - 2022
  • [47] IMPACT OF HYPERPHOSPHATEMIA CORRECTIVE THERAPY ON CARDIOVASCULAR RISK MARKER - FGF-23 IN CHRONIC KIDNEY DISEASE PATIENTS
    Milovanov, Yuriy
    Dudareva, Anna
    Milovanova, Ludmila
    Kozlovskaya, Lidia
    Mukhin, Nikolay
    Lebedeva, Marina
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 1469 - 1470
  • [48] FGF-23 AND KLOTHO LEVELS IN RENAL TRANSPLANT PATIENTS AND COMPARISON WITH HEMODIALYSIS PATIENTS
    Baloglu, Ismail
    Turkmen, Kultigin
    Selcuk, N. Yilmaz
    Tonbul, H. Zeki
    Erdur, F. Mehmet
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [49] FGF-23 is associated with cardiac troponin T and mortality in hemodialysis patients
    Holden, Rachel M.
    Beseau, David
    Booth, Sarah L.
    Adams, Michael A.
    Garland, Jocelyn S.
    Morton, Ross A.
    Collier, Christine P.
    Foley, Robert N.
    HEMODIALYSIS INTERNATIONAL, 2012, 16 (01) : 53 - 58
  • [50] FGF-23, vascular calcification, and cardiovascular diseases in chronic hemodialysis patients
    Diana Moldovan
    Ioan Moldovan
    Crina Rusu
    Ina Kacso
    Ioan Mihai Patiu
    Mirela Gherman-Caprioara
    International Urology and Nephrology, 2014, 46 : 121 - 128
12345